Heinrich MC - Search Results

1

Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways.

Pantaleo MA, Nannini M, Corless CL, Heinrich MC. Pantaleo MA, et al. Among authors: heinrich mc. Cancer Med. 2015 Jan;4(1):101-3. doi: 10.1002/cam4.325. Epub 2014 Aug 28. Cancer Med. 2015. PMID: 25165019 Free PMC article.

2

Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit.

Rader AE, Avery A, Wait CL, McGreevey LS, Faigel D, Heinrich MC. Rader AE, et al. Among authors: heinrich mc. Cancer. 2001 Aug 25;93(4):269-75. doi: 10.1002/cncr.9041. Cancer. 2001. PMID: 11507701

3

PDGFRA activating mutations in gastrointestinal stromal tumors.

Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. Heinrich MC, et al. Science. 2003 Jan 31;299(5607):708-10. doi: 10.1126/science.1079666. Epub 2003 Jan 9. Science. 2003. PMID: 12522257

4

Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT.

Bauer S, Corless CL, Heinrich MC, Dirsch O, Antoch G, Kanja J, Seeber S, Schütte J. Bauer S, et al. Among authors: heinrich mc. Cancer Chemother Pharmacol. 2003 Mar;51(3):261-5. doi: 10.1007/s00280-002-0564-x. Epub 2003 Feb 26. Cancer Chemother Pharmacol. 2003. PMID: 12655446

5

Absence of BRAF and NRAS mutations in uveal melanoma.

Cruz F 3rd, Rubin BP, Wilson D, Town A, Schroeder A, Haley A, Bainbridge T, Heinrich MC, Corless CL. Cruz F 3rd, et al. Among authors: heinrich mc. Cancer Res. 2003 Sep 15;63(18):5761-6. Cancer Res. 2003. PMID: 14522897

6

Is KIT an important therapeutic target in small cell lung cancer?

Heinrich MC. Heinrich MC. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5825-8. Clin Cancer Res. 2003. PMID: 14676102 No abstract available.

7

Biology of gastrointestinal stromal tumors: KIT mutations and beyond.

Duensing A, Heinrich MC, Fletcher CD, Fletcher JA. Duensing A, et al. Among authors: heinrich mc. Cancer Invest. 2004;22(1):106-16. doi: 10.1081/cnv-120027585. Cancer Invest. 2004. PMID: 15069768 Review.

8

The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.

West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, van de Rijn M. West RB, et al. Among authors: heinrich mc. Am J Pathol. 2004 Jul;165(1):107-13. doi: 10.1016/S0002-9440(10)63279-8. Am J Pathol. 2004. PMID: 15215166 Free PMC article.

9

Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas.

Heinrich MC, Corless CL. Heinrich MC, et al. Cancer Treat Res. 2004;120:129-50. doi: 10.1007/1-4020-7856-0_8. Cancer Treat Res. 2004. PMID: 15217222 Review. No abstract available.

10

KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.

Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CD. Medeiros F, et al. Among authors: heinrich mc. Am J Surg Pathol. 2004 Jul;28(7):889-94. doi: 10.1097/00000478-200407000-00007. Am J Surg Pathol. 2004. PMID: 15223958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results